4-Isobutylphenylboronic Acid is an intermediate used to prepare thiophenesulfonamides as endothelin receptor antagonists. it is also used to synthesize thalidomide analogs with the proinflammatory cytokine Tumor Necrosis Factor (TNF) expression inhibition activities.